Adolescents with Human Immunodeficiency Virus (HIV) in Botswana, South Africa, Thailand, Uganda and the United States who ...
The immune system remains seriously out-of-whack—in an inflammatory state of overactivation and impaired ...
We can commemorate National Black HIV/AIDS Awareness Day, but we cannot afford to commemorate another decade of disparities.
An integrase inhibitor-based antiretroviral regimen is noninferior to a boosted protease inhibitor-based regimen in treatment ...
The immune system remains seriously out-of-whack – in an inflammatory state of overactivation and impaired functionality – ...
The Substance Abuse and Mental Health Services Administration has reportedly canceled thousands of grants supporting mental ...
A new study offers good news from Uganda — although the cuts in U.S. aid cast a shadow over the reduction in deaths of ...
The global pharmaceutical industry will generate more than $1.2 trillion in sales in 2026, according to Statista. The oncology segment alone is expected to generate $232 billion in sales this year.
Pharmaceutical Technology on MSN
JPM26: HIV pipeline dosing optionality gives Gilead advantage
Speaking at the J.P. Morgan Healthcare Conference 2026, CEO Daniel O’Day said that the company has seven pipeline drugs for ...
Among treatment-naive adults with advanced HIV disease, integrase inhibitors are a preferred first-line therapy over protease inhibitors.
Up to additional $20M in milestone and other future payments Future Pak becomes exclusive U.S. marketer for Mytesi ® and Canalevia ®-CA1 Jaguar continues to be the manufacturer of Mytesi and Canalevia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback